WILSON TROY EDWARD 4
4 · Kura Oncology, Inc. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-11-13+182,500→ 429,353 total
Holdings
- 279,194(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents 1/3rd of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.